Overprescribing and rational therapeutics: barriers to change and opportunities to improve

Research output: Contribution to journalReview articlepeer-review

Authors

  • Frances Bennett
  • Robin Ferner
  • Reecha Sofat

Colleges, School and Institutes

Abstract

There is increasing national and international interest in overprescribing and polypharmacy, and the burden that the inappropriate use of multiple medicines can place on individual patients and on society as a whole. This paper explores the challenges faced by prescribers and pharmacists wishing to reduce polypharmacy, including the uncertainties about the risks and benefits of continuing or stopping individual drugs. We discuss the factors influencing us to prescribe-which may lead to overprescribing-including the increasing number of guidelines, perceived patient pressure and advertising. We offer a critical appraisal of the tools currently available to clinicians and pharmacists aiming to rationalise medicines, and finally a systems-wide approach to improving overprescribing and problematic polypharmacy.

Details

Original languageEnglish
Pages (from-to)34-38
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume87
Issue number1
Early online date26 Mar 2020
Publication statusPublished - Jan 2021

Keywords

  • medicines optimisation, overprescribing, polypharmacy, rational therapeutics